REGN
Regeneron Pharmaceuticals Inc
Price:  
697.05 
USD
Volume:  
1,629,098.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Regeneron WACC - Weighted Average Cost of Capital

The WACC of Regeneron Pharmaceuticals Inc (REGN) is 9.4%.

The Cost of Equity of Regeneron Pharmaceuticals Inc (REGN) is 9.60%.
The Cost of Debt of Regeneron Pharmaceuticals Inc (REGN) is 4.25%.

Range Selected
Cost of equity 8.50% - 10.70% 9.60%
Tax rate 9.50% - 11.60% 10.55%
Cost of debt 4.00% - 4.50% 4.25%
WACC 8.3% - 10.5% 9.4%
WACC

Regeneron WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1 1.04
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.50% 10.70%
Tax rate 9.50% 11.60%
Debt/Equity ratio 0.04 0.04
Cost of debt 4.00% 4.50%
After-tax WACC 8.3% 10.5%
Selected WACC 9.4%